1. The risk of micro and macrovascular disease in Egyptian patients with diabetes and peripheral arterial disease
- Author
-
Alaa H. Abdel-Hamid, Ayman Elsamadony, Eman El-Sebaee, Aasem Saif, Shrook Mousa, Shereen Sadik El-Sawy, Maha Assem, and Samar Amin
- Subjects
medicine.medical_specialty ,endocrine system diseases ,Arterial disease ,030204 cardiovascular system & hematology ,03 medical and health sciences ,0302 clinical medicine ,peripheral arterial disease ,Internal medicine ,Diabetes mellitus ,Internal Medicine ,medicine ,cardiovascular diseases ,030212 general & internal medicine ,ankle/brachial index ,Macrovascular disease ,diabetes ,business.industry ,nutritional and metabolic diseases ,medicine.disease ,RC31-1245 ,Peripheral ,body regions ,macrovascular ,microvascular ,business ,Research Article - Abstract
Aim: The aim of this study was to assess the prevalence of micro- and macrovascular disease in Egyptian patients with diabetes mellitus (DM) and peripheral arterial disease (PAD). Methods: The study included 161 Egyptian patients with DM and PAD (91.3% had type 2 DM and 67.1% were females). Mean diabetes duration was 14.2 ± 5.2 years. Full history, clinical and fundus examination as well as laboratory investigations were done. PAD was diagnosed through assessment of ankle/brachial index (ABI) by Doppler ultrasonography. Results: ABI was 1.3 in 66.5% of patients. A significant positive correlation was found between abnormal ABI and diabetes duration, ischemic heart disease (IHD), diabetic retinopathy and neuropathy, foot ulcers, elevated blood pressure (BP), creatinine, urine albumin/creatinine ratio (ACR) and triglycerides and a significant negative correlation with HDL. Multivariate regression analysis revealed that the independent predictors for PAD in patients with ABI< 0.9 were neuropathy, creatinine, triglyceride, LDL, urine ACR and low HDL, and in patients with ABI >1.3 were IHD, neuropathy, elevated diastolic BP and triglyceride. Conclusion: The risk of micro- and macrovascular disease is high in Egyptian patients with diabetes and PAD. Early diagnosis and good control of risk factors could reduce PAD progression.
- Published
- 2021